BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 20167722)

  • 1. L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Miccoli P; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2010 Mar; 17(1):231-9. PubMed ID: 20167722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.
    Fiore E; Rago T; Latrofa F; Provenzale MA; Piaggi P; Delitala A; Scutari M; Basolo F; Di Coscio G; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2011 Aug; 18(4):429-37. PubMed ID: 21565972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
    Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter].
    Pascual Corrales E; Príncipe RM; Laguna Muro S; Martínez Regueira F; Alcalde Navarrete JM; Guillén Grima F; Galofré JC
    Endocrinol Nutr; 2012 Mar; 59(3):169-73. PubMed ID: 22325789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
    Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology.
    Niedźwiecki S; Kuzdak K; Kaczka K; Pomorski L
    Wiad Lek; 2007; 60(5-6):228-30. PubMed ID: 17966885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
    Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
    Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the treatment with L-thyroxine: lack of correspondence between objectives and results].
    Negro R; Dazzi D; Pezzarossa A
    Minerva Endocrinol; 2000 Mar; 25(1):11-7. PubMed ID: 11148845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
    Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
    J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease.
    Rago T; Fiore E; Scutari M; Santini F; Di Coscio G; Romani R; Piaggi P; Ugolini C; Basolo F; Miccoli P; Pinchera A; Vitti P
    Eur J Endocrinol; 2010 Apr; 162(4):763-70. PubMed ID: 20083557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer.
    Montesano T; Durante C; Attard M; Crocetti U; Meringolo D; Bruno R; Tumino S; Rubello D; Al-Nahhas A; Colandrea M; Maranghi M; Travascio L; Ronga G; Torlontano M
    Biomed Pharmacother; 2007 Sep; 61(8):468-71. PubMed ID: 17553654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationship between thyroid nodularity and TSH level.
    Sachmechi I; Vahedi M; Nalamasu S; Vuppalanchi R
    Mt Sinai J Med; 2005 Jan; 72(1):33-5. PubMed ID: 15682260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between serum TSH concentration and thyroid cancer.
    Boelaert K
    Endocr Relat Cancer; 2009 Dec; 16(4):1065-72. PubMed ID: 19620248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyroglobulin level in patients with diffuse and nodular goiter, after therapeutic application of stable iodine.
    Djurica SN; Cirović M; Tasovac-Ponomarev D
    Exp Clin Endocrinol; 1992; 99(1):21-5. PubMed ID: 1628693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of a sensitive TSH-RIA].
    Seidel C; Ziegelitz D; Weber A; Dittmer T; Gerl H; Knappe G; Correns HJ
    Endokrinologie; 1982 Oct; 80(2):181-93. PubMed ID: 6819129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the clinically significant TSH response to TRH in patients with nodular goitre.
    Kirkegaard C; Bregengård C
    Horm Metab Res; 1988 Jun; 20(6):357-9. PubMed ID: 3138170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
    Appetecchia M
    Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Incidental' and 'non-incidental' thyroid papillary microcarcinomas are two different entities.
    Provenzale MA; Fiore E; Ugolini C; Torregrossa L; Morganti R; Molinaro E; Miccoli P; Basolo F; Vitti P
    Eur J Endocrinol; 2016 Jun; 174(6):813-20. PubMed ID: 27032694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.